Desai Nihar R, Ross Joseph S, Kwon Ji Young, Herrin Jeph, Dharmarajan Kumar, Bernheim Susannah M, Krumholz Harlan M, Horwitz Leora I
Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut2Center for Outcomes Research and Evaluation, New Haven, Connecticut.
Center for Outcomes Research and Evaluation, New Haven, Connecticut3Section of General Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut4Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut5Department of Health Policy and Management, Yale University School of Public Health, New Haven, Connecticut.
JAMA. 2016 Dec 27;316(24):2647-2656. doi: 10.1001/jama.2016.18533.
Readmission rates declined after announcement of the Hospital Readmission Reduction Program (HRRP), which penalizes hospitals for excess readmissions for acute myocardial infarction (AMI), heart failure (HF), and pneumonia.
To compare trends in readmission rates for target and nontarget conditions, stratified by hospital penalty status.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of Medicare fee-for-service beneficiaries older than 64 years discharged between January 1, 2008, and June 30, 2015, from 2214 penalty hospitals and 1283 nonpenalty hospitals. Difference-interrupted time-series models were used to compare trends in readmission rates by condition and penalty status.
Hospital penalty status or target condition under the HRRP.
Thirty-day risk adjusted, all-cause unplanned readmission rates for target and nontarget conditions.
The study included 48 137 102 hospitalizations of 20 351 161 Medicare beneficiaries. In January 2008, the mean readmission rates for AMI, HF, pneumonia, and nontarget conditions were 21.9%, 27.5%, 20.1%, and 18.4%, respectively, at hospitals later subject to financial penalties and 18.7%, 24.2%, 17.4%, and 15.7% at hospitals not subject to penalties. Between January 2008 and March 2010, prior to HRRP announcement, readmission rates were stable across hospitals (except AMI at nonpenalty hospitals). Following announcement of HRRP (March 2010), readmission rates for both target and nontarget conditions declined significantly faster for patients at hospitals later subject to financial penalties compared with those at nonpenalized hospitals (for AMI, additional decrease of -1.24 [95% CI, -1.84 to -0.65] percentage points per year relative to nonpenalty discharges; for HF, -1.25 [95% CI, -1.64 to -0.86]; for pneumonia, -1.37 [95% CI, -1.80 to -0.95]; and for nontarget conditions, -0.27 [95% CI, -0.38 to -0.17]; P < .001 for all). For penalty hospitals, readmission rates for target conditions declined significantly faster compared with nontarget conditions (for AMI, additional decline of -0.49 [95% CI, -0.81 to -0.16] percentage points per year relative to nontarget conditions [P = .004]; for HF, -0.90 [95% CI, -1.18 to -0.62; P < .001]; and for pneumonia, -0.57 [95% CI, -0.92 to -0.23; P < .001]). In contrast, among nonpenalty hospitals, readmissions for target conditions declined similarly or more slowly compared with nontarget conditions (for AMI, additional increase of 0.48 [95% CI, 0.01-0.95] percentage points per year [P = .05]; for HF, 0.08 [95% CI, -0.30 to 0.46; P = .67]; for pneumonia, 0.53 [95% CI, 0.13-0.93; P = .01]). After HRRP implementation in October 2012, the rate of change for readmission rates plateaued (P < .05 for all except pneumonia at nonpenalty hospitals), with the greatest relative change observed among hospitals subject to financial penalty.
Medicare fee-for-service patients at hospitals subject to penalties under the HRRP had greater reductions in readmission rates compared with those at nonpenalized hospitals. Changes were greater for target vs nontarget conditions for patients at the penalized hospitals but not at the other hospitals.
医院再入院率降低计划(HRRP)宣布后,再入院率有所下降,该计划会对急性心肌梗死(AMI)、心力衰竭(HF)和肺炎的超额再入院情况对医院进行处罚。
比较目标疾病和非目标疾病的再入院率趋势,并按医院处罚状态进行分层。
设计、设置和参与者:对2008年1月1日至2015年6月30日期间从2214家受处罚医院和1283家未受处罚医院出院的64岁以上医疗保险按服务收费受益人进行回顾性队列研究。采用差异中断时间序列模型比较不同疾病和处罚状态下的再入院率趋势。
HRRP下的医院处罚状态或目标疾病。
目标疾病和非目标疾病30天风险调整后的全因非计划再入院率。
该研究纳入了20351161名医疗保险受益人的48137102次住院治疗。2008年1月,后来受到经济处罚的医院中,AMI、HF、肺炎和非目标疾病的平均再入院率分别为21.9%、27.5%、20.1%和18.4%,未受处罚的医院中分别为18.7%、24.2%、17.4%和15.7%。在2008年1月至2010年3月HRRP宣布之前,各医院的再入院率保持稳定(未受处罚医院的AMI除外)。HRRP宣布后(2010年3月),与未受处罚医院的患者相比,后来受到经济处罚的医院中目标疾病和非目标疾病的再入院率下降明显更快(对于AMI,相对于未受处罚的出院患者,每年额外下降-1.24[95%CI,-1.84至-0.65]个百分点;对于HF,-1.25[95%CI,-1.64至-0.86];对于肺炎,-1.37[95%CI,-1.80至-0.95];对于非目标疾病,-0.27[95%CI,-0.38至-0.17];所有P<0.001)。对于受处罚医院,目标疾病的再入院率相对于非目标疾病下降明显更快(对于AMI,相对于非目标疾病每年额外下降-0.49[95%CI,-0.81至-0.16]个百分点[P=0.004];对于HF,-0.90[95%CI,-1.18至-0.62;P<0.001];对于肺炎,-0.57[95%CI,-0.92至-0.23;P<0.001])。相比之下,在未受处罚医院中,目标疾病的再入院率与非目标疾病相比下降相似或更慢(对于AMI,每年额外增加0.48[95%CI,0.01-0.95]个百分点[P=0.05];对于HF,0.08[95%CI,-0.30至0.46;P=0.67];对于肺炎,0.53[95%CI,0.13-0.93;P=0.01])。2012年10月HRRP实施后,再入院率的变化率趋于平稳(未受处罚医院的肺炎除外,所有P<0.05),在受到经济处罚的医院中观察到的相对变化最大。
与未受处罚医院的医疗保险按服务收费患者相比,HRRP下受处罚医院的患者再入院率降低幅度更大。对于受处罚医院的患者,目标疾病的变化大于非目标疾病,但其他医院并非如此。